The data displays the leading three therapy areas in the U.S. from 2012 to 2016, based on spending. In 2016, some 45.5 billion USD were spent in the area of oncologics, which ranked this therapeutic area first.
Antidiabetics | 22.3 | 25.6 | 33.7 | 43.9 | 51.5 |
Oncologics | 25.6 | 28.1 | 33.1 | 39.1 | 45.5 |
Autoimmune | 15.2 | 18.3 | 23.5 | 30.2 | 37.2 |